Toronto Heart Valve Symposium 2019
The advances in assessment and treatment of valvular disease continues to evolve rapidly in recent years. Non-invasive evaluation, transcatheter therapies and surgical techniques are undergoing progressive change. This symposium is aimed at providing surgeons and cardiologists working in the field with the latest updates in each of these areas.
Learning Objectives:
Session 1:
1. To recall recent randomized trials for MR.
2. To explain the updates on TMVR development.
Session 2:
1. To apply evolving concepts in TAVR.
2. To explain management of AV disease: young patients and those with AVR failure.
Plenary:
To examine surgical management of HF
Session 3:
|
1. To recognize the natural history of tricuspid regurgitation and impact on clinical outcomes 2. To define advances in imaging and intervention for TR. ACCREDITATION INFORMATION Royal College of Physicians and Surgeons of Canada – Section 1 This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, approved by Continuing Professional Development, Faculty of Medicine, University of Toronto. You may claim a maximum of 6.5 hours (credits are automatically calculated). |
REGISTRATION
On-line registration is now closed.
Join us tomorrow to register on-site!
Credit card, cheque and cash are all acceptable payments.